Fluorine-18–labelled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography or Magnetic Resonance Imaging to Diagnose and Localise Prostate Cancer. A Prospective Single-arm Paired Comparison (PEDAL)

医学 前列腺癌 正电子发射断层摄影术 前列腺 磁共振成像 放射科 活检 谷氨酸羧肽酶Ⅱ 前列腺活检 前瞻性队列研究 核医学 接收机工作特性 癌症 病理 内科学
作者
Lih‐Ming Wong,Tom Sutherland,Elisa Perry,Vy Anh Tran,Tim Spelman,Niall M. Corcoran,Nathan Lawrentschuk,Henry H. Woo,Daniel Lenaghan,Nicholas Buchan,Kevin Bax,James Symons,Ahmed Goolam,Venu Chalasani,Justin Hegarty,Lauren Thomas,Alexandar Christov,Michael Ng,Hadia Khanani,Su‐Faye Lee
出处
期刊:European Urology Oncology [Elsevier BV]
被引量:5
标识
DOI:10.1016/j.euo.2024.01.002
摘要

Background and objectiveMultiparametric magnetic resonance imaging (mpMRI) of the prostate is used for prostate cancer diagnosis. However, mpMRI has lower sensitivity for small tumours. Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA-PET/CT) offers increased sensitivity over conventional imaging. This study aims to determine whether the diagnostic accuracy of 18F-DCFPyL PSMA-PET/CT was superior to that of mpMRI for detecting prostate cancer (PCa) at biopsy.MethodsBetween 2020 and 2021, a prospective multicentre single-arm phase 3 imaging trial enrolled patients with clinical suspicion for PCa to have both mpMRI and PSMA-PET/CT (thorax to thigh), with reviewers blinded to the results of other imaging. Multiparametric MRI was considered positive for Prostate Imaging Reporting and Data System (PIRADS) 3–5. PSMA-PET/CT was assessed quantitatively (positive maximum standardised uptake value [SUVmax] >7) and qualitatively (five-point lexicon of certainty). Patients underwent targeted and systematic biopsy, with the technique at the discretion of the treating urologist. Clinically significant PCa (csPCa) was defined as International Society of Urological Pathology grade group (GG) ≥2. The primary outcome was the diagnostic accuracy for detecting PCa, reported as sensitivity, specificity, negative predictive value (NPV), and area under the curve (AUC) of the receiver operating curve. The secondary endpoints included a comparison of the diagnostic accuracy for detecting csPCa, assessing gains in combining PMSA-PET/CT with mpMRI to mpMRI alone.Key findings and limitationsOf the 236 patients completing both mpMRI and PSMA-PET/CT, 184 (76.7%) had biopsy. Biopsy histology was benign (n = 73), GG 1 (n = 27), and GG ≥2 (n = 84). The diagnostic accuracy of mpMRI for detecting PCa (AUC 0.76; 95% confidence interval [CI] 0.69, 0.82) was higher than that of PSMA-PET/CT (AUC 0.63; 95% CI 0.56, 0.70, p = 0.03). The diagnostic accuracy of mpMRI for detecting csPCa (AUC 0.72; 95% CI 0.67, 0.78) was higher than that of PSMA-PET/CT (AUC 0.62; 95% CI 0.55, 0.69) but not statistically significant (p = 0.27). A combination of PSMA-PET/CT and mpMRI showed excellent sensitivity (98.8%, 95% CI 93.5%, 100%) and NPV (96%, 95% CI 79.6%, 99.9%) over mpMRI alone (86.9% and 80.7%, respectively, p = 0.01). Thirty-two patients (13.6%) had metastatic disease. They tended to be older (68.4 vs 65.1 yr, p = 0.023), and have higher prostate-specific antigen (PSA; median PSA 9.6 vs 6.2ng/ml, p < 0.001) and abnormal prostate on digital rectal examination (78.2% vs 44.1%, p < 0.001).Conclusions and clinical implicationsMultiparametric MRI had superior diagnostic accuracy to PSMA-PET/CT for detecting PCa, though the difference is not significant in case of csPCa detection. A combination of mpMRI and PSMA-PET/CT showed improved sensitivity and NPV. PSMA-PET/CT could be considered for diagnostic use in patients unable to have mpMRI or those with concerning clinical features but negative mpMRI.Patient summaryIn this trial, we compared the ability of 18F-labelled prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA-PET/CT) with that of multiparametric magnetic resonance imaging (mpMRI) to diagnose prostate cancer by biopsy in a prostate-specific antigen screening population. We found that MRI was superior to PSMA to diagnose prostate cancer, though there was no difference in ability to diagnose clinically significant prostate cancer. PSMA-PET/CT could be considered for diagnostic use in patients unable to have mpMRI or those with concerning clinical features but negative mpMRI. Combining MRI with PSMA-PET increases the negative predictive value over MRI alone and may help men avoid invasive prostate biopsy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
2秒前
2秒前
3秒前
木木发布了新的文献求助10
3秒前
3秒前
岁月静好发布了新的文献求助10
5秒前
二二二完成签到 ,获得积分10
5秒前
8秒前
8秒前
呆萌滑板发布了新的文献求助10
9秒前
所所应助书记采纳,获得10
9秒前
9秒前
coconut完成签到 ,获得积分10
10秒前
小橙子给蔚蓝绽放的求助进行了留言
11秒前
11秒前
11秒前
Yuxin应助周冬利采纳,获得10
11秒前
研友_89eBO8完成签到 ,获得积分10
12秒前
ccq发布了新的文献求助10
12秒前
13秒前
13秒前
Leo完成签到,获得积分10
14秒前
所所应助小天采纳,获得10
14秒前
14秒前
小橙子应助水博士采纳,获得20
14秒前
hehehe发布了新的文献求助10
14秒前
lijunlhc完成签到,获得积分10
15秒前
自然白安完成签到,获得积分10
15秒前
流川发布了新的文献求助10
16秒前
zhy完成签到,获得积分10
17秒前
橙子发布了新的文献求助10
17秒前
18秒前
自然白安发布了新的文献求助10
18秒前
toda_erica完成签到,获得积分10
18秒前
123321完成签到 ,获得积分10
18秒前
humingxuan完成签到,获得积分10
19秒前
Megumi发布了新的文献求助10
20秒前
23秒前
Wh完成签到 ,获得积分10
24秒前
高分求助中
【请各位用户详细阅读此贴后再求助】科研通的精品贴汇总(请勿应助) 10000
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 1000
Global Eyelash Assessment scale (GEA) 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4045849
求助须知:如何正确求助?哪些是违规求助? 3583534
关于积分的说明 11389428
捐赠科研通 3310798
什么是DOI,文献DOI怎么找? 1822063
邀请新用户注册赠送积分活动 894214
科研通“疑难数据库(出版商)”最低求助积分说明 816067